SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001599298-24-000004
Filing Date
2024-01-03
Accepted
2024-01-03 16:06:38
Documents
15
Period of Report
2024-01-03
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K smmt-20240103.htm   iXBRL 8-K 29321
2 EX-99.1 a2024_prx0103xjpmannounc.htm EX-99.1 7996
6 a2024_prx0103xjpmannounc001.jpg GRAPHIC 245256
7 a2024_prx0103xjpmannounc002.jpg GRAPHIC 252165
  Complete submission text file 0001599298-24-000004.txt   851938

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20240103.xsd EX-101.SCH 1907
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20240103_lab.xml EX-101.LAB 23834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20240103_pre.xml EX-101.PRE 12512
9 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20240103_htm.xml XML 2736
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 24506333
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)